Global Bioresorbable Polymer-based Implants Market Growth (Status and Outlook) 2025-2031

The global Bioresorbable Polymer-based Implants market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Bioresorbable polymer-based implants are being widely used for fracture fixation in orthopedic surgery. Orthopedic implants, such as interference screws, plates, pins, suture anchors, meniscal repair implants, and simple fracture fixation implants, are the most commonly used resorbable implants for anterior cruciate ligament reconstruction, shoulder surgery, meniscal repair, and fracture care. When these implants are added to the body, they perform the desired action, and once done, these implants get absorbed in the body by themselves. These resorbable polymer-based implants include sutures, screws, stents, plates, pins, and others used in various orthopedics sub-applications, such as trauma, hip, knee, spine, joint, and other injuries. These implants break down naturally after implantation, during the healing and supporting process.

United States market for Bioresorbable Polymer-based Implants is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Bioresorbable Polymer-based Implants is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Bioresorbable Polymer-based Implants is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Bioresorbable Polymer-based Implants players cover Bezwada Biomedical, LLC, Evonik Industries AG, Foster Corporation, Ashland, Musashino Chemical Laboratory, Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Bioresorbable Polymer-based Implants Industry Forecast” looks at past sales and reviews total world Bioresorbable Polymer-based Implants sales in 2024, providing a comprehensive analysis by region and market sector of projected Bioresorbable Polymer-based Implants sales for 2025 through 2031. With Bioresorbable Polymer-based Implants sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioresorbable Polymer-based Implants industry.

This Insight Report provides a comprehensive analysis of the global Bioresorbable Polymer-based Implants landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bioresorbable Polymer-based Implants portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bioresorbable Polymer-based Implants market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioresorbable Polymer-based Implants and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioresorbable Polymer-based Implants.

This report presents a comprehensive overview, market shares, and growth opportunities of Bioresorbable Polymer-based Implants market by product type, application, key players and key regions and countries.

Segmentation by Type:

Polylactic Acid (PLA)

Polyglycolic Acid (PGA)

Polydioxanone

Polycaprolactone (PCL)

Others

Segmentation by Application:

Orthopedic Devices

Drug Delivery

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Bezwada Biomedical, LLC

Evonik Industries AG

Foster Corporation

Ashland

Musashino Chemical Laboratory, Ltd.

Huizhou Foryou Medical Devices Co., Ltd.

Polysciences, Inc.

BMG

Poly-Med Incorporated

Reva Medical, LLC.

KLS Martin

Corbion

LACTEL Absorbable Polymers

DSM

MAST Biosurgery

Zeus

Arctic Biomaterials

Please note: The report will take approximately 2 business days to prepare and deliver.